Abbott Laboratories Total Liabilities and Share Holders Equity 2010-2024 | ABT

Abbott Laboratories total liabilities and share holders equity for the quarter ending June 30, 2024 was $73.017B, a 0.46% decline year-over-year.

  • Abbott Laboratories total liabilities and share holders equity for 2023 was $73.214B, a 1.64% decline from 2022.
  • Abbott Laboratories total liabilities and share holders equity for 2022 was $74.438B, a 1.01% decline from 2021.
  • Abbott Laboratories total liabilities and share holders equity for 2021 was $75.196B, a 3.65% increase from 2020.

Abbott Laboratories Total Liabilities and Share Holders Equity 2010-2024 | ABT

  • Abbott Laboratories total liabilities and share holders equity for 2023 was $73.214B, a 1.64% decline from 2022.
  • Abbott Laboratories total liabilities and share holders equity for 2022 was $74.438B, a 1.01% decline from 2021.
  • Abbott Laboratories total liabilities and share holders equity for 2021 was $75.196B, a 3.65% increase from 2020.